Financials
Financial year 2025
Brupharma from Brugge, company number BE0407579845, closed financial year 2025 with a result of € -743 after tax. For that financial year Brupharma recorded a gross margin of € 75,839 and equity of € 174,489. Compared with financial year 2024, the result moved from € 3,712 to € -743. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 6, 2026.
€ 174,489
▼ 23% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -743
▼ still € 3,712 profit in 2024
Profit after tax over the fiscal year.
€ 183,705
▲ € 164,024 vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € 155,889.
People and assets in 2025
€ 4,310
▲ 4% vs 2024
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 25,618
▼ 52% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 3,745
▼ 19% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 2,871
▲ 32% vs 2024
Taxes, VAT and social contributions still to pay.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 99,582 | € 113,092 | € 114,672 | € 75,839 | ▼ 34% |
| Profit after taxes | € 136 | € 1,838 | € 3,712 | € -743 | ▼ € 4,455 |
| Equity | € 255,682 | € 257,520 | € 225,232 | € 174,489 | ▼ 23% |
| Total debts | € 155,337 | € 136,284 | € 169,826 | € 185,514 | ▲ 9% |
| Cash | € 6,778 | € 82,321 | € 19,681 | € 183,705 | ▲ € 164,024 |
| Land & buildings | € 147,853 | € 139,052 | € 130,251 | € 121,450 | ▼ 7% |
| Retained profit | € 237,082 | € 238,920 | € 206,632 | € 155,889 | ▼ 25% |
| Dividend | € 0 | € 0 | € 36,000 | € 50,000 | ▲ 39% |
| Bank debt | € 148,000 | € 0 | € 0 | € 0 | |
| Balance sheet total | € 411,019 | € 393,803 | € 395,058 | € 360,003 | ▼ 9% |
Key figures of Brupharma, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Brupharma?
What happened at Brupharma in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 743 (▼ € 4,455 vs 2024). Source: NBB ↗
- New establishment in Brugge. KBO
- Start of the company according to the CBE. KBO
In short
From € 136 profit in 2022 to € 743 loss in 2025.
Paid € 5,853 in corporate taxes since 2022.
Best year ever: 2024, with € 3,712 profit.
Paid out € 86,000 in dividends to the owners in total.
Management
Behind Brupharma is Jean Paul Waelkens.
Directors
According to the 2025 annual accounts
Jean Paul Waelkens
Director
Establishments
Establishment units
Physical locations of this company
Smedenstraat 73
8000 Brugge
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Website
Technologies
Hosting & Email
Email provider
Self-hosted
Hosting
CLOUDFLARENET - Cloudflare, Inc., US
DNS
Cloudflare DNS
Website info
Features
Security
Network
Details
- Company number
- 0407.579.845
- VAT number
- BE 0407.579.845
- Registered office
- Smedenstraat 73, 8000 Brugge
- Names & denominations
- Brupharma
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 12 November 1970
- Peppol
- Active · Active since 17 Dec 2024
- Contact
- apotheekwaelkens.be
- Activities · NACE
Apothekers
Detailhandel in farmaceutische producten